This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gillgrass, A. E.
Right arrow Articles by Kaushic, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gillgrass, A. E.
Right arrow Articles by Kaushic, C.

 Previous Article  |  Next Article 

Journal of Virology, September 2003, p. 9845-9851, Vol. 77, No. 18
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.18.9845-9851.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Prolonged Exposure to Progesterone Prevents Induction of Protective Mucosal Responses following Intravaginal Immunization with Attenuated Herpes Simplex Virus Type 2

Amy E. Gillgrass, Ali A. Ashkar, Kenneth L. Rosenthal, and Charu Kaushic*

Center of Gene Therapeutics, Department of Pathology and Molecular Medicine, McMaster University Health Sciences Center, Hamilton, Ontario, Canada

Received 23 April 2003/ Accepted 23 June 2003

Depo-Provera (Depo) is a long-acting progestational formulation that is a popular form of contraception for women. In animal models of sexually transmitted diseases, it is used to facilitate infection. Here we report that treatment with Depo, in a mouse model of genital herpes simplex virus type 2 (HSV-2), altered immune responses depending on the length of time that animals were exposed to Depo prior to immunization. Mice immunized intravaginally (i.vag.) with an attenuated strain (TK-) of HSV-2 following longer (15 days) exposure to Depo (Depo 15 group) failed to show protection when challenged with wild-type HSV-2. In contrast, mice that were immunized shortly after Depo treatment (5 days; Depo 5 group) were fully protected and showed no genital pathology after HSV-2 challenge. High viral titers were detected in the vaginal washes of the Depo 15 group up to 6 days postchallenge. In contrast, no viral shedding was observed beyond day 3 postchallenge in the Depo 5 group. Following i.vag. TK- immunization, high levels of gamma interferon (IFN-{gamma}) were detected locally in vaginal washes of the Depo 5 group but not the Depo 15 group. After HSV-2 challenge, an early peak of IFN-{gamma} in the Depo 5 group coincided with clearance of the virus. In Depo 15 animals IFN-{gamma} was present throughout the 6 days postinfection. HSV-2-specific T-cell cytokine responses measured in the lymph node cells of Depo 5 TK--immunized mice indicated a significantly higher Th1 response than that of Depo 15 TK--immunized mice. The protection after HSV-2 challenge in the Depo 5 group correlated with increased local HSV-2 glycoprotein B (gB)-specific immunoglobulin G (IgG) and IgA responses seen in the vaginal secretions. The Depo 15 group had poor gB-specific antibody responses in the genital tract after HSV-2 challenge. These results indicate that longer exposure to Depo leads to poor innate and adaptive immune responses to HSV-2 that fail to protect mice from subsequent genital challenges.


* Corresponding author. Mailing address: Department of Pathology and Molecular Medicine, HSC, 4H30F, McMaster University, 1200 Main St. West, Hamilton, Ontario, Canada L8P 3Z5. Phone: (905) 525-9140, ext. 22988. Fax: (905) 522-6750. E-mail: kaushic{at}mcmaster.ca.


Journal of Virology, September 2003, p. 9845-9851, Vol. 77, No. 18
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.18.9845-9851.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Arruvito, L., Giulianelli, S., Flores, A. C., Paladino, N., Barboza, M., Lanari, C., Fainboim, L. (2008). NK Cells Expressing a Progesterone Receptor Are Susceptible to Progesterone-Induced Apoptosis. J. Immunol. 180: 5746-5753 [Abstract] [Full Text]  
  • Gill, N., Deacon, P. M., Lichty, B., Mossman, K. L., Ashkar, A. A. (2006). Induction of Innate Immunity against Herpes Simplex Virus Type 2 Infection via Local Delivery of Toll-Like Receptor Ligands Correlates with Beta Interferon Production.. J. Virol. 80: 9943-9950 [Abstract] [Full Text]  
  • Pal, S., Peterson, E. M., de la Maza, L. M. (2005). Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria. Infect. Immun. 73: 8153-8160 [Abstract] [Full Text]  
  • Yim, K. C., Carroll, C. J., Tuyama, A., Cheshenko, N., Carlucci, M. J., Porter, D. D., Prince, G. A., Herold, B. C. (2005). The Cotton Rat Provides a Novel Model To Study Genital Herpes Infection and To Evaluate Preventive Strategies. J. Virol. 79: 14632-14639 [Abstract] [Full Text]  
  • Kawana, K., Kawana, Y., Schust, D. J. (2005). Female Steroid Hormones Use Signal Transducers and Activators of Transcription Protein-Mediated Pathways to Modulate the Expression of T-bet in Epithelial Cells: A Mechanism for Local Immune Regulation in the Human Reproductive Tract. Mol. Endocrinol. 19: 2047-2059 [Abstract] [Full Text]  
  • Gupta, S., Janani, R., Bin, Q., Luciw, P., Greer, C., Perri, S., Legg, H., Donnelly, J., Barnett, S., O'Hagan, D., Polo, J. M., Vajdy, M. (2005). Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles. J. Virol. 79: 7135-7145 [Abstract] [Full Text]  
  • Gillgrass, A. E., Fernandez, S. A., Rosenthal, K. L., Kaushic, C. (2005). Estradiol Regulates Susceptibility following Primary Exposure to Genital Herpes Simplex Virus Type 2, while Progesterone Induces Inflammation. J. Virol. 79: 3107-3116 [Abstract] [Full Text]  
  • Gillgrass, A. E., Tang, V. A., Towarnicki, K. M., Rosenthal, K. L., Kaushic, C. (2005). Protection against Genital Herpes Infection in Mice Immunized under Different Hormonal Conditions Correlates with Induction of Vagina-Associated Lymphoid Tissue. J. Virol. 79: 3117-3126 [Abstract] [Full Text]